Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2007 1
2008 2
2009 1
2011 2
2012 2
2013 4
2014 3
2015 7
2016 6
2017 7
2018 8
2019 9
2020 8
2021 2
2022 6
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Grade 4 Small Bowel Mucositis or Stomatitis by Functional or Symptomatic Classification, CTCAE"
Page 1
Prevalences of peri-implantitis and peri-implant mucositis: systematic review and meta-analysis.
Lee CT, Huang YW, Zhu L, Weltman R. Lee CT, et al. J Dent. 2017 Jul;62:1-12. doi: 10.1016/j.jdent.2017.04.011. Epub 2017 May 3. J Dent. 2017. PMID: 28478213 Review.
Weighted mean implant-based and subject-based peri-implant mucositis prevalences were 29.48% (CI: [22.65, 36.32]) and 46.83% (CI: [38.30, 55.36]) respectively. Functional time and implant to subject ratio were associated with subject-based peri-implantitis prevalenc …
Weighted mean implant-based and subject-based peri-implant mucositis prevalences were 29.48% (CI: [22.65, 36.32]) and 46.83% (CI: [38 …
Peri-implant health and disease. A systematic review of current epidemiology.
Derks J, Tomasi C. Derks J, et al. J Clin Periodontol. 2015 Apr;42 Suppl 16:S158-71. doi: 10.1111/jcpe.12334. J Clin Periodontol. 2015. PMID: 25495683 Review.
MATERIAL & METHODS: Data were extracted from identified studies. Meta-analyses for prevalence of peri-implant mucositis and peri-implantitis were performed. The effect of function time and disease definition on the prevalence of peri-implantitis was evaluated by …
MATERIAL & METHODS: Data were extracted from identified studies. Meta-analyses for prevalence of peri-implant mucositis and peri- …
Systemic interventions for treatment of Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS/TEN overlap syndrome.
Jacobsen A, Olabi B, Langley A, Beecker J, Mutter E, Shelley A, Worley B, Ramsay T, Saavedra A, Parker R, Stewart F, Pardo Pardo J. Jacobsen A, et al. Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013130. doi: 10.1002/14651858.CD013130.pub2. Cochrane Database Syst Rev. 2022. PMID: 35274741 Free PMC article. Review.
IVIG versus no IVIG It is uncertain if there is any difference between IVIG (0.2 to 0.5 g/kg cumulative dose over three days) and no IVIG in risk of disease-specific mortality (RR 0.33, 95% CI 0.04 to 2.91); time to complete re-epithelialisation (mean difference (MD) -2.93 days, …
IVIG versus no IVIG It is uncertain if there is any difference between IVIG (0.2 to 0.5 g/kg cumulative dose over three days) and no IVIG in …
Systemic Immunomodulating Therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis.
Zimmermann S, Sekula P, Venhoff M, Motschall E, Knaus J, Schumacher M, Mockenhaupt M. Zimmermann S, et al. JAMA Dermatol. 2017 Jun 1;153(6):514-522. doi: 10.1001/jamadermatol.2016.5668. JAMA Dermatol. 2017. PMID: 28329382 Free PMC article. Review.
Glucocorticosteroids were associated with a survival benefit for patients in all 3 analyses but were statistically significant in only one (aggregated data: OR, 0.5; 95%% CI, 0.3-1.01; IPD, unstratified: OR, 0.7; 95% CI, 0.5-0.97; IPD, stratified: OR, 0.8; 95% CI, 0.4-1.3) …
Glucocorticosteroids were associated with a survival benefit for patients in all 3 analyses but were statistically significant in only one ( …
Clinicopathological Features and Management of Appendiceal Mucoceles: A Systematic Review.
Morano WF, Gleeson EM, Sullivan SH, Padmanaban V, Mapow BL, Shewokis PA, Esquivel J, Bowne WB. Morano WF, et al. Am Surg. 2018 Feb 1;84(2):273-281. Am Surg. 2018. PMID: 29580358 Review.
Pathologic evaluation revealed the following: cystadenoma/low-grade appendiceal mucinous neoplasm (54%), unspecified/benign (25%), retention cyst (14.1%), cystadenocarcinoma (4.2%), and mucosal hyperplasia (2.9%). All 11 (4.2%) patients with cystadenoc …
Pathologic evaluation revealed the following: cystadenoma/low-grade appendiceal mucinous neoplasm (54%), unspecified/benign (25%), re …
Risk indicators for peri-implant mucositis: a systematic literature review.
Renvert S, Polyzois I. Renvert S, et al. J Clin Periodontol. 2015 Apr;42 Suppl 16:S172-86. doi: 10.1111/jcpe.12346. J Clin Periodontol. 2015. PMID: 25496066 Review.
Smoking has also been identified as an independent risk indicator whereas the overall evidence for surface roughness, residual cement, the dimension of the keratinized tissue and time of implant in function is weak. There are limited data available to support systemic cond …
Smoking has also been identified as an independent risk indicator whereas the overall evidence for surface roughness, residual cement, the d …
Role of human leukocyte antigen in anti-epileptic drugs-induced Stevens-Johnson Syndrome/toxic epidermal necrolysis: A meta-analysis.
Rashid M, Rajan AK, Chhabra M, Kashyap A, Chandran VP, Venkataraman R, Nair S, Thunga G. Rashid M, et al. Seizure. 2022 Nov;102:36-50. doi: 10.1016/j.seizure.2022.09.011. Epub 2022 Sep 17. Seizure. 2022. PMID: 36183454 Free article. Review.
There was a significantly higher risk of Carbamazepine-induced SJS/TEN with HLA-A (OR: 1.50; 95% CI: 1.03 to 2.17), HLA-B (OR: 1.94; 95% CI: 1.45 to 2.58), HLA-C (OR: 7.83; 95% CI: 4.72 to 12.98), and HLA-DRB1 (OR: 2.82; 95% CI: 1.94 to 4.12). Lamotrigine-induced SJ …
There was a significantly higher risk of Carbamazepine-induced SJS/TEN with HLA-A (OR: 1.50; 95% CI: 1.03 to 2.17), HLA-B (OR: 1.94; 95% CI: …
Effectiveness of honey on radiation-induced oral mucositis, time to mucositis, weight loss, and treatment interruptions among patients with head and neck malignancies: A meta-analysis and systematic review of literature.
Co JL, Mejia MB, Que JC, Dizon JM. Co JL, et al. Head Neck. 2016 Jul;38(7):1119-28. doi: 10.1002/hed.24431. Epub 2016 Mar 29. Head Neck. 2016. PMID: 27028991 Review.
BACKGROUND: Mucositis is a disabling effect of radiotherapy in head and neck cancers. There is no current standard on management of radiation-induced mucositis. Honey has been shown to reduce radiation-induced mucositis. ...
BACKGROUND: Mucositis is a disabling effect of radiotherapy in head and neck cancers. There is no current standard on management of r …
Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis.
Normando AGC, Rocha CL, de Toledo IP, de Souza Figueiredo PT, Dos Reis PED, De Luca Canto G, Guerra ENS. Normando AGC, et al. Support Care Cancer. 2017 Sep;25(9):2969-2988. doi: 10.1007/s00520-017-3783-8. Epub 2017 Jun 16. Support Care Cancer. 2017. PMID: 28623401 Review.
PURPOSE: The aim of this study was to evaluate the capability of biomarkers to predict the risk of oral mucositis in head and neck cancer patients, as well as to assess the correlation between these biomarkers and the severity of mucositis. ...The methodological qua …
PURPOSE: The aim of this study was to evaluate the capability of biomarkers to predict the risk of oral mucositis in head and neck ca …
The efficacy and safety of pharmacological treatments for lymphangioleiomyomatosis.
Wang Q, Luo M, Xiang B, Chen S, Ji Y. Wang Q, et al. Respir Res. 2020 Feb 14;21(1):55. doi: 10.1186/s12931-020-1316-3. Respir Res. 2020. PMID: 32059669 Free PMC article.
BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare, low-grade multisystem neoplastic disease. Most LAM patients are at a high risk of losing lung function at an accelerated rate and developing progressive dyspnea. ...Most of the adverse events during pharmacologic …
BACKGROUND: Lymphangioleiomyomatosis (LAM) is a rare, low-grade multisystem neoplastic disease. Most LAM patients are at a high risk …
63 results